Precision Medicine

While healthcare is not applying the same kind of data understanding that other service rely on, precision medicine will bring that to the fore, expert says.

CRISPR has sparked considerable excitement for precision medicine, but patient safety, enzyme delivery and today’s level of disease understanding are limiting mainstream adoption.

An ambitious project aims to provide insight on “the most diverse collection of people in human history.”

[Also: Politico uncovers more funding indiscretions from Patrick Soon-Shiong]Despite company losing $41 million in the first quarter, biotech mogul Patrick Soon-Shiong defended his company’s work and chastised what he called false reports.

New cancer test requires less DNA than previous versions.

While tests like those offered by 23andMe help patients become proactive in their healthcare, providers and the industry aren’t ready to interpret them.

Program has tapped internationally recognized bioinformatics and genomics expert to lead the effort.

Jeff Gordon & Sohn Precision Medicine Fund at Memorial Sloan Kettering Cancer Center is funded by a $200,000 grant to combat cancer in children.

The two-day event features more than 20 experts sharing insights about precision medicine in the here-and-now and the promise it holds for the future.

The upcoming event will address emerging technologies, leadership insights, challenges to overcome and practicable advice about thriving in the increasingly data-rich healthcare world.